Designed mimics of islet amyloid polypeptide as inhibitors of protein aggregation and cell degeneration in Alzheimer's disease and type 2 diabetes

被引:0
|
作者
Yan, L-M [1 ]
Velkova, A. [1 ]
Tatarek-Nossol, M. [2 ]
Kracklauer, M. [1 ]
Bakou, M. [1 ]
Andreetto, E. [1 ]
Kapurniotu, A. [1 ]
机构
[1] Tech Univ Munich, Div Peptide Biochem, Freising Weihenstephan, Germany
[2] Rhein Westfal TH Aachen, Inst Biochem & Mol Cell Biol, Aachen, Germany
关键词
IAPP;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:S56 / S57
页数:2
相关论文
共 50 条
  • [11] ISLET AMYLOID POLYPEPTIDE - THE CAUSE OF TYPE-2 DIABETES
    BRETHERTONWATT, D
    BLOOM, SR
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1991, 2 (06): : 203 - 206
  • [12] Islet Amyloid Polypeptide: A Partner in Crime With Aβ in the Pathology of Alzheimer's Disease
    Raimundo, Ana F.
    Ferreira, Sofia
    Martins, Ivo C.
    Menezes, Regina
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2020, 13
  • [13] Protein Misfolding and Aggregation in Alzheimer's Disease and Type 2 Diabetes Mellitus
    Ashraf, Ghulam M.
    Greig, Nigel H.
    Khan, Taqi A.
    Hassan, Iftekhar
    Tabrez, Shams
    Shakil, Shazi
    Sheikh, Ishfaq A.
    Zaidi, Syed K.
    Akram, Mohammad
    Jabir, Nasimudeen R.
    Firoz, Chelaprom K.
    Naeem, Aabgeena
    Alhazza, Ibrahim M.
    Damanhouri, Ghazi A.
    Kamal, Mohammad A.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (07) : 1280 - 1293
  • [14] Soluble IAPP mimics as tailored IAPP receptor agonists and inhibitors of protein aggregation in type 2 diabetes (T2D) and Alzheimer's disease (AD)
    Kapurniotu, A.
    Yan, L-M.
    Velkova, A.
    Tatarek-Nossol, M.
    Andreetto, E.
    BIOPOLYMERS, 2011, 96 (04) : 477 - 477
  • [15] An investigation into the potential action of polyphenols against human Islet Amyloid Polypeptide aggregation in type 2 diabetes
    Mahboob, Anns
    Senevirathne, Degiri Kalana Lasanga
    Paul, Pradipta
    Nabi, Faisal
    Khan, Rizwan Hasan
    Chaari, Ali
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2023, 225 : 318 - 350
  • [16] Recent Advances in the Discovery of Therapeutics to Curtail Islet Amyloid Polypeptide Aggregation for Type 2 Diabetes Treatment
    Smith, Alyssa A.
    Moore, Kendall B. E.
    Ambs, Patrick M.
    Saraswati, Akella Prasanth
    Fortin, Jessica S.
    ADVANCED BIOLOGY, 2022, 6 (10):
  • [17] Rationally Designed Peptides and Peptidomimetics as Inhibitors of Amyloid-β (Aβ) Aggregation: Potential Therapeutics of Alzheimer's Disease
    Goyal, Deepti
    Shuaib, Suniba
    Mann, Sukhmani
    Goyal, Bhupesh
    ACS COMBINATORIAL SCIENCE, 2017, 19 (02) : 55 - 80
  • [18] Self-Assembled Nanochaperones Inhibit the Aggregation of Human Islet Amyloid Polypeptide Associated with Type 2 Diabetes
    Niu, Haihong
    Hou, Xiaoxue
    Zhang, Yanli
    Wu, Xiaohui
    Deng, Fei
    Huang, Fan
    Shi, Linqi
    Ma, Rujiang
    ACS MACRO LETTERS, 2021, 10 (06) : 662 - 670
  • [19] Prion protein-derived cell-penetrating peptide inhibits type II diabetes associated islet amyloid polypeptide aggregation and cytotoxicity
    Oh, Yujeong
    Howarth, Madeline
    Loganathan, Palanikumar
    Maity, Debabrata
    Mustafa, Morad
    Kumar, Sunil
    Magzoub, Mazin M.
    BIOPHYSICAL JOURNAL, 2024, 123 (03) : 73A - 73A
  • [20] Islet amyloid polypeptide & amyloid beta peptide roles in Alzheimer's disease: two triggers, one disease
    Ferreira, Sofia
    Raimundo, Ana F.
    Menezes, Regina
    Martins, Ivo C.
    NEURAL REGENERATION RESEARCH, 2021, 16 (06) : 1127 - 1130